| Financial Year |
March 31 2023 |
| Monetary Funds |
1,294,112,476.80 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
404,086,870.42 |
| Advances to Suppliers |
146,425,179.45 |
| Other Receivables |
658,575,446.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
11,106,509,106.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
100,019,405.28 |
| Total Current Assets |
13,710,792,490.53 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
22,292,127.37 |
| Long-term Equity Investment |
80,798,891.32 |
| Investment Properties |
396,785,785.35 |
| Fixed Assetes |
78,818,591.73 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
974,222.92 |
| R&D expenses |
-- |
| Goodwill |
9,446,847.38 |
| Long-Term Deferred and Prepaid Expenses |
22,104,628.41 |
| Deferred Income Tax Assets |
1,390,497,288.53 |
| Other Non-Current Assets |
2,750,873.08 |
| Sub-Total of Non-Current Assets |
2,068,680,543.32 |
| Total Assets |
15,779,473,033.85 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
424,879,548.32 |
| Accounts Received In Advance |
1,256,391.62 |
| Employee Compensation Payable |
199,128,150.85 |
| Taxes Payable |
3,872,677,504.17 |
| Interest Payable |
-- |
| Dividend Payable |
12,202,676.04 |
| Other payables |
1,488,142,735.12 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
218,456,766.65 |
| Other Current Liabilities |
79,539,635.66 |
| Sub-Total of Current Liabilities |
7,234,231,755.46 |
| Long-term Loans |
3,868,882,344.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
766,612.52 |
| Deferred Income Tax Liabilities |
174,168.87 |
| Other Non-Current Liabilities |
125,716,075.26 |
| Sub-Total of Non-Current Liabilities |
4,065,958,633.94 |
| Total Liabilities |
11,300,190,389.40 |
| Paid-In Capital(Or Share Stock) |
595,979,092.00 |
| Capital Surplus |
80,488,045.38 |
| Surplus Reserve |
48,886,605.81 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,704,272,933.68 |
| Minority Stockholder's Interest |
52,554,531.51 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,426,728,112.94 |
| Owner's Equity（Stockholder's Equity） |
4,479,282,644.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,779,473,033.85 |
